INAB logo

IN8bio, Inc.

INAB
Healthcare|Biotechnology|US
$0.93
+0.10 (+11.63%)
DCF Value
$5.49
Tangible Book / Share
$0.73
Cash / Share
$0.72
Next Earnings Report
Mar 11, 2027
EPS est. -$0.65
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Jun 1, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (2)

Dec 2026
Est. completion
P1P2Glioblastoma
A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma
NCT05664243n=4
Jan 2027
Est. completion
P1Acute Myeloid Leukemia
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
NCT03533816n=38

Recent Press Releases

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Nov 6, 2026 · GlobeNewsWire
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Oct 6, 2026 · GlobeNewsWire
IN8bio to Present at Sidoti Small-Cap Virtual Conference
Sep 22, 2026 · GlobeNewsWire
IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference
Sep 10, 2026 · GlobeNewsWire
IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development
Sep 9, 2026 · GlobeNewsWire

SEC Filings (80)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 202610-QQuarterly reportDocumentIndex
Nov 5, 20268-KMaterial eventDocumentIndex
Aug 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 7, 2026S-8Employee stock planDocumentIndex
Aug 6, 202610-QQuarterly reportDocumentIndex
Aug 6, 20268-KMaterial eventDocumentIndex
Jun 1, 20268-KMaterial eventDocumentIndex
Jun 1, 2026424B5Offering prospectusDocumentIndex
May 29, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
May 19, 2026EFFECTDocumentIndex
May 18, 2026S-3/AShelf registrationDocumentIndex
May 7, 2026S-8 POSEmployee stock planDocumentIndex
May 7, 2026S-8 POSEmployee stock planDocumentIndex
May 7, 2026S-8 POSEmployee stock planDocumentIndex
May 7, 2026S-8 POSEmployee stock planDocumentIndex
May 7, 2026S-8 POSEmployee stock planDocumentIndex
May 7, 2026S-8Employee stock planDocumentIndex
May 7, 202610-QQuarterly reportDocumentIndex
May 7, 20268-KMaterial eventDocumentIndex
Mar 26, 2026ARSAnnual report to holdersDocumentIndex
Mar 26, 2026DEFA14AProxy / shareholder voteDocumentIndex
Mar 26, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 12, 202610-KAnnual reportDocumentIndex
Mar 12, 20268-KMaterial eventDocumentIndex
Mar 2, 2026SC 13GPassive 5%+ stakeDocumentIndex
Feb 27, 20268-KMaterial eventDocumentIndex
Feb 17, 2026SC 13GPassive 5%+ stakeDocumentIndex
Feb 9, 20268-KMaterial eventDocumentIndex
Jan 30, 2026424B3Offering prospectusDocumentIndex
Jan 29, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 28, 2026EFFECTDocumentIndex
Jan 20, 2026S-3Shelf registrationDocumentIndex
Jan 2, 2026SC 13DActivist / 5%+ stakeDocumentIndex
Dec 30, 2025DDocumentIndex
Dec 30, 2025SC 13GPassive 5%+ stakeDocumentIndex
Dec 29, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Dec 22, 2025SC 13GPassive 5%+ stakeDocumentIndex
Dec 19, 20258-KMaterial eventDocumentIndex
Nov 24, 20258-KMaterial eventDocumentIndex
Nov 7, 2025S-3Shelf registrationDocumentIndex